Device for treating microcirculation disturbance of thrombotic microvascular disease

Abstract

The utility model discloses a device for treating microcirculation disturbance of thrombotic microvascular diseases, which can be used as a blood detection kit and comprises a fixed sleeve, a detachable built-in sleeve is arranged on the inner wall of the fixed sleeve, a filter screen is mounted on the side face of the built-in sleeve, and a filter screen is mounted on the filter screen. A replaceable blood filter strip is arranged in the filter screen, a detachable movable cover is arranged at the tail of the fixed sleeve, a discharge port is formed in the inner wall of the fixed sleeve, and a connecting pipe is arranged between the movable cover and the discharge head. Through cooperative treatment among the built-in reactor, the filter screen and the blood filter strip, the problem that the quality of the treated blood cannot be systematically counted and adjusted due to the fact that medical staff cannot monitor the treated blood in real time is avoided, and the quality of the treated blood cannot be systematically counted and adjusted when the medical staff treats a patient in the later period. The illness state of the patient is influenced.

Description

Technical Field

[0001] The utility model relates to the technical field of disorder treatment, in particular to a device for treating microcirculatory disorders of thrombotic microvascular diseases. Background Art

[0002] Thrombotic microangiopathy and microcirculatory disorders are a class of clinical diseases. The treatment of platelets in the patient's blood and the reduction of platelet aggregation can prevent blood coagulation and improve blood flow. Classical thrombotic microangiopathy mainly refers to hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP). Among them, the number of patients with TTP secondary to other diseases and drugs is increasing, and the incidence rate is on the rise. The disease is very dangerous, with a poor prognosis and a short course of disease. If not treated in time, the mortality rate is as high as 80~90%. The functional loss of metalloproteinase ADAMTS13 is the most important cause of TPP.

[0003] At present, the clinical treatment of thrombotic microvascular diseases mainly includes two aspects: one is to detect and monitor the microcirculation state through equipment such as CN200710139657.6; the other is to treat through blood processing devices. However, the existing blood processing devices lack real-time monitoring means for blood quality during the treatment process, resulting in the inability to adjust the treatment parameters in time.

[0004] Therefore, in order to solve this problem, the utility model provides a device for treating microcirculatory disorders caused by thrombotic microvascular diseases. Utility Model Content

[0005] The utility model aims to solve the problems in the prior art and proposes a device for treating microcirculatory disorders of thrombotic microvascular diseases.

[0006] In order to achieve the above-mentioned purpose, the utility model adopts the following technical scheme: a device for treating microcirculatory disorders caused by thrombotic microvascular diseases, comprising a fixed sleeve, the inner wall of the fixed sleeve is provided with a detachable built-in sleeve, the side of the built-in sleeve is provided with a filter screen, the interior of the filter screen is provided with a replaceable blood filter strip, the tail of the fixed sleeve is provided with a detachable movable cover, the inner wall of the fixed sleeve is provided with a discharge port, the inner wall of the discharge port is fixedly connected to a support frame, the internal thread of the support frame is provided with a built-in reactor, the top of the fixed sleeve is provided with a discharge head, and a connecting pipe is provided between the movable cover and the discharge head.

[0007] Preferably, a clamping groove is provided at the tail of the fixed sleeve, and a clamping ring is fixedly connected to the tail of the built-in sleeve, and the clamping ring is placed on the inner wall of the clamping groove.

[0008] Preferably, the surface of the fixing sleeve is in close contact with the protection pad, and the protection pad is distributed on both sides of the fixing sleeve.

[0009] Preferably, a rubber stopper is tightly mounted on the top of the discharge head, and the rubber stopper is medical rubber.

[0010] Preferably, a butt joint pipe is installed on the top of the movable cover, and a thread is formed on the surface of the butt joint pipe.

[0011] Preferably, the support frame and the built-in reactor are threaded adjustment structures.

[0012] Preferably, the support frame and the built-in reactor are piston adjustment structures.

[0013] Preferably, the surface of the movable cover is provided with a plurality of anti-slip pads, and the anti-slip pads are rectangular in shape.

[0014] Compared with the prior art, the utility model provides a device for treating microcirculatory disorders caused by thrombotic microvascular diseases, which has the following beneficial effects:

[0015] 1. The device for treating microcirculatory disorders of thrombotic microvascular diseases, through the coordinated processing between the built-in reactor, the filter net and the blood filter strip, avoids the medical staff being unable to monitor the blood after treatment in real time, resulting in the inability to systematically count and adjust the blood quality after each treatment, which affects the patient's condition when the medical staff uses it to treat the patient later.

[0016] 2. The device for treating microcirculatory disorders of thrombotic microvascular diseases has a movable cover and a support frame, which is convenient for medical staff to use and can be cleaned and disassembled regularly, thereby ensuring the cleanliness and hygiene of the interior and avoiding the breeding of bacteria. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 This is a schematic diagram of the structure of the device for treating microcirculatory disorders caused by thrombotic microvascular diseases proposed by the utility model.

[0018] Figure 2 This is a front view of the structure of the device for treating microcirculatory disorders caused by thrombotic microvascular diseases proposed by the utility model.

[0019] Figure 3 This is a structural expansion diagram of the device for treating microcirculatory disorders caused by thrombotic microvascular diseases proposed by the utility model.

[0020] Figure 4 This is a structural side view of the device for treating microcirculatory disorders caused by thrombotic microvascular diseases proposed by the utility model.

[0021] Figure 5 The utility model provides a device for treating microcirculatory disorders of thrombotic microvascular diseases Figure 2 Enlarged view of area A in the middle.

[0022] In the figure: 1. fixed sleeve; 101. slot; 102. protective pad; 2. built-in sleeve; 201. snap ring; 3. filter screen; 4. blood filter strip; 5. movable cover; 501. docking tube; 502. anti-slip pad; 6. discharge port; 7. support frame; 8. built-in reactor; 9. discharge head; 901. rubber plug; 10. connecting tube. DETAILED DESCRIPTION

[0023] The technical solutions in the embodiments of the present invention will be described clearly and completely below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments.

[0024] In the description of the present invention, it should be understood that the terms "upper", "lower", "front", "back", "left", "right", "top", "bottom", "inside", "outside", etc., indicating directions or positional relationships, are based on the directions or positional relationships shown in the accompanying drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific direction, be constructed and operated in a specific direction, and therefore should not be understood as a limitation on the present invention.

[0025] Reference Figures 1 to 5 A device for treating microcirculatory disorders caused by thrombotic microvascular diseases comprises a fixed sleeve 1, a detachable built-in sleeve 2 is arranged on the inner wall of the fixed sleeve 1, a filter screen 3 is installed on the side of the built-in sleeve 2, a replaceable blood filter strip 4 is arranged inside the filter screen 3, a detachable movable cover 5 is arranged at the tail of the fixed sleeve 1, a discharge port 6 is installed on the inner wall of the fixed sleeve 1, a support frame 7 is fixedly connected to the inner wall of the discharge port 6, a built-in reactor 8 is arranged on the internal thread of the support frame 7, a discharge head 9 is installed on the top of the fixed sleeve 1, and a connecting pipe 10 is arranged between the movable cover 5 and the discharge head 9.

[0026] In the utility model, when in use, the medical staff puts the built-in sleeve 2 into the inner wall of the fixed sleeve 1, and threadedly connects the movable cover 5 with the fixed sleeve 1, so that the medical staff can assemble the movable cover 5 and the fixed sleeve 1 together. The medical staff connects the pipe of the blood bag to the top of the movable cover 5, and the blood enters the inner wall of the built-in sleeve 2 through the movable cover 5, and is processed and used through the blood filter strip 4. The processed blood is discharged into the inner wall of the fixed sleeve 1 through the filter net 3, and the blood is tested and used through the built-in reactor 8, so that the medical staff can understand and count the blood processing situation. When the blood is unqualified, the blood is discharged through the connecting tube 10 for circulation and processing.

[0027] In some embodiments, the von Willebrand factor cleaving enzyme (ADAMTS-13) can be detected by the built-in reactor 8, which has the advantages of short time consumption, timely clinical information feedback, low detection cost, benefit to patients, accurate results, high precision, large throughput, etc. Through this application, TTP patients and HUS patients can be distinguished during TMA screening, so that different treatment methods can be used according to different diseases, truly achieving precision medicine, playing an auxiliary monitoring role in the treatment process of TTP patients, and playing an early warning role for the prognosis of TTP patients.

[0028] Reference Figure 1 A clamping groove 101 is provided at the tail of the fixed sleeve 1 , and a clamping ring 201 is fixedly connected to the tail of the built-in sleeve 2 , and the clamping ring 201 is placed on the inner wall of the clamping groove 101 .

[0029] In the present invention, when the medical staff puts the built-in sleeve 2 into the inner wall of the fixed sleeve 1, the clamping ring 201 is clamped into the inner wall of the clamping groove 101, so that the medical staff can limit the position of the built-in sleeve 2 conveniently.

[0030] Reference Figure 1 , the surface of the fixed sleeve 1 is in close contact with the protective pad 102 , and the protective pad 102 is distributed on both sides of the fixed sleeve 1 .

[0031] In the utility model, the protective pad 102 is in close contact with the surface of the fixed sleeve 1, so that the medical staff can hold it with their right hand when using it, thereby avoiding affecting the later use of the medical staff.

[0032] Reference Figure 1 A rubber stopper 901 is tightly mounted on the top of the discharge head 9, and the rubber stopper 901 is medical rubber.

[0033] In the utility model, a rubber plug 901 is tightly installed on the top of the discharge head 9, and the rubber plug 901 is medical rubber, which is convenient for medical staff to insert one end of the blood transfusion device into the rubber plug 901 for use, thereby avoiding blood overflow at the end of use, affecting the normal use of medical staff.

[0034] Reference Figure 1 and Figure 2 A butt joint pipe 501 is installed on the top of the movable cover 5, and a thread is provided on the surface of the butt joint pipe 501.

[0035] In the utility model, a butt joint pipe 501 is installed on the top of the movable cover 5 and a thread is provided on the surface of the butt joint pipe 501, so that medical staff can quickly connect it with other equipment when using it.

[0036] Reference Figure 5 The support frame 7 and the built-in reactor 8 are threaded adjustment structures.

[0037] In the utility model, the support frame 7 and the built-in reactor 8 are threaded adjustment structures, which facilitates medical personnel to quickly disassemble and install the built-in reactor 8.

[0038] Reference Figure 5 The support frame 7 and the built-in reactor 8 are piston adjustment structures.

[0039] In another embodiment of the present application, the built-in reactor may also be referred to as a detector or a reagent kit.

[0040] In a further embodiment, relevant detection reactants can be placed in a kit or a reactor, such as using an ADAMTS-13 system.

[0041] In the utility model, the support frame 7 and the built-in reactor 8 are piston-adjustable structures, which makes it convenient for medical personnel to install and disassemble the support frame 7 in a different way.

[0042] Reference Figure 1 and Figure 2 The surface of the movable cover 5 is provided with a plurality of anti-skid pads 502 , and the anti-skid pads 502 are rectangular in shape.

[0043] In the utility model, a plurality of anti-skid pads 502 are respectively provided on the surface of the movable cover 5, so that the medical staff can conveniently rotate the movable cover 5 for use, thereby preventing the medical staff's hands from slipping when using the movable cover 5, thereby preventing the use effect from being affected.

[0044] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes within the technical scope disclosed by the present invention according to the technical scheme and the utility model concept of the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A device for treating microcirculatory disorders caused by thrombotic microvascular diseases, comprising a fixed sleeve (1), characterized in that: The inner wall of the fixed sleeve (1) is provided with a detachable built-in sleeve (2), a filter screen (3) is installed on the side of the built-in sleeve (2), a replaceable blood filter strip (4) is arranged inside the filter screen (3), a detachable movable cover (5) is arranged at the tail of the fixed sleeve (1), a discharge port (6) is installed on the inner wall of the fixed sleeve (1), a support frame (7) is fixedly connected to the inner wall of the discharge port (6), a built-in reactor (8) is arranged on the internal thread of the support frame (7), a discharge head (9) is installed on the top of the fixed sleeve (1), and a connecting pipe (10) is arranged between the movable cover (5) and the discharge head (9).

2. The device for treating microcirculatory disorders caused by thrombotic microvascular diseases according to claim 1, characterized in that: The tail of the fixed sleeve (1) is provided with a clamping groove (101), and the tail of the built-in sleeve (2) is fixedly connected with a clamping ring (201), and the clamping ring (201) is placed on the inner wall of the clamping groove (101).

3. The device for treating microcirculatory disorders caused by thrombotic microvascular diseases according to claim 1, characterized in that: The surface of the fixed sleeve (1) is in close contact with the protective pad (102), and the protective pad (102) is distributed on both sides of the fixed sleeve (1).

4. The device for treating microcirculatory disorders caused by thrombotic microvascular diseases according to claim 1, characterized in that: A rubber stopper (901) is tightly mounted on the top of the discharge head (9), and the rubber stopper (901) is medical rubber.

5. The device for treating microcirculatory disorders caused by thrombotic microvascular diseases according to claim 1, characterized in that: A butt joint pipe (501) is installed on the top of the movable cover (5), and a thread is formed on the surface of the butt joint pipe (501).

6. The device for treating microcirculatory disorders caused by thrombotic microvascular diseases according to claim 1, characterized in that: The support frame (7) and the built-in reactor (8) are threaded adjustment structures.

7. The device for treating microcirculatory disorders caused by thrombotic microvascular diseases according to claim 1, characterized in that: The support frame (7) and the built-in reactor (8) are piston adjustment structures.

8. The device for treating microcirculatory disorders caused by thrombotic microvascular diseases according to claim 1, characterized in that: A plurality of anti-skid pads (502) are respectively provided on the surface of the movable cover (5), and the anti-skid pads (502) are rectangular in shape.

Images